2019 AGS老年人潜在不当用药Beers标准(更新版)

2019-01-29 美国老年医学会 J Am Geriatr Soc. 2019.00:1-21,

2019年1月,美国老年医学会(AGS)更新了老年人潜在不当用药Beers标准。是对2015年更新版Beers标准的更新,其中包括了30种老年人在一般情形下避免使用的药物或药物类别,和40种在某些疾病或综合征下慎用或避免应用的药物或药物类别。 新标准减少了16种药物,一些是由于并非老年人使用所特有的问题;另一些药物在美国不再使用,比如噻氯匹定和喷他佐辛。

中文标题:

2019 AGS老年人潜在不当用药Beers标准(更新版)

英文标题:

American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults

发布机构:

美国老年医学会

发布日期:

2019-01-29

简要介绍:

2019年1月,美国老年医学会(AGS)更新了老年人潜在不当用药Beers标准。是对2015年更新版Beers标准的更新,其中包括了30种老年人在一般情形下避免使用的药物或药物类别,和40种在某些疾病或综合征下慎用或避免应用的药物或药物类别。 新标准减少了16种药物,一些是由于并非老年人使用所特有的问题;另一些药物在美国不再使用,比如噻氯匹定和喷他佐辛。

拓展指南:药物相关指南:

相关资料下载:
[AttachmentFileName(sort=1, fileName=【医脉通】2019+AGS老年人潜在不当用药Beers标准(更新版).pdf), AttachmentFileName(sort=100, fileName=2019 AGS老年人潜在不当用药Beers标准(更新版))] GetToolGuiderByIdResponse(projectId=1, id=5021a1c001e0a1cc, title=2019 AGS老年人潜在不当用药Beers标准(更新版), enTitle=American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults, guiderFrom=J Am Geriatr Soc. 2019.00:1-21,, authorId=null, author=, summary=2019年1月,美国老年医学会(AGS)更新了老年人潜在不当用药Beers标准。是对2015年更新版Beers标准的更新,其中包括了30种老年人在一般情形下避免使用的药物或药物类别,和40种在某些疾病或综合征下慎用或避免应用的药物或药物类别。 新标准减少了16种药物,一些是由于并非老年人使用所特有的问题;另一些药物在美国不再使用,比如噻氯匹定和喷他佐辛。 , cover=, journalId=null, articlesId=null, associationId=234, associationName=美国老年医学会, associationIntro=The American Geriatrics Society (AGS) is a not-for-profit organization of close to 6,000 health professionals devoted to improving the health, independence and quality of life of all older people. The Society provides leadership to healthcare professionals, policy makers and the public by implementing and advocating for programs in patient care, research, professional and public education, and public policy., copyright=0, guiderPublishedTime=Tue Jan 29 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年1月,美国老年医学会(AGS)更新了老年人潜在不当用药Beers标准。是对2015年更新版Beers标准的更新,其中包括了30种老年人在一般情形下避免使用的药物或药物类别,和40种在某些疾病或综合征下慎用或避免应用的药物或药物类别。 新标准减少了16种药物,一些是由于并非老年人使用所特有的问题;另一些药物在美国不再使用,比如噻氯匹定和喷他佐辛。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>药物</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=d75451c00169885c" title="2018 ECIL意见书:血液学和肿瘤学中免疫治疗和分子靶向药物的相关感染" target=_blank>2018 ECIL意见书:血液学和肿瘤学中免疫治疗和分子靶向药物的相关感染</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=38bdd1c001698629" title="2019 PHE指南:应用抗病毒药物治疗和预防季节性流感(v9.1)" target=_blank>2019 PHE指南:应用抗病毒药物治疗和预防季节性流感(v9.1)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=46d891c00169522b" title="合理应用药物治疗前列腺炎的临床专家意见" target=_blank>合理应用药物治疗前列腺炎的临床专家意见</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f6fd41c00169a008" title="药物临床试验机构经费管理·广东共识2019(征求意见稿)" target=_blank>药物临床试验机构经费管理·广东共识2019(征求意见稿)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=2a4631c001693064" title="2018 WHO建议:妊娠期严重高血压的药物治疗" target=_blank>2018 WHO建议:妊娠期严重高血压的药物治疗</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%8D%AF%E7%89%A9" target=_blank>有关药物更多指南</a></ul>, tagList=[TagDto(tagId=86742, tagName=不当用药), TagDto(tagId=86743, tagName=Beers标准)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=19, categoryName=老年医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=16291, appHits=219, showAppHits=0, pcHits=8734, showPcHits=9922, likes=199, shares=10, comments=3, approvalStatus=1, publishedTime=Wed Feb 20 00:39:54 CST 2019, publishedTimeString=2019-01-29, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Feb 20 00:39:54 CST 2019, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 10:13:22 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=【医脉通】2019+AGS老年人潜在不当用药Beers标准(更新版).pdf), AttachmentFileName(sort=100, fileName=2019 AGS老年人潜在不当用药Beers标准(更新版))])
【医脉通】2019+AGS老年人潜在不当用药Beers标准(更新版).pdf
下载请点击:
2019 AGS老年人潜在不当用药Beers标准(更新版)
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2121607, encodeId=4b91212160e04, content=很需要,感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cba5468764, createdName=ms8000001004052089, createdTime=Fri Mar 24 16:23:35 CST 2023, time=2023-03-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1014498, encodeId=7eba10144984d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cac5462324, createdName=ms6000000828783892, createdTime=Sat Sep 04 10:12:43 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918788, encodeId=a9c7918e8857, content=很好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/fa25a8dd4d134574b62e806c7e35dea4/bc6f7d5f2e0d4474a8483e2a7a323f89.jpg, createdBy=21d25454526, createdName=ms1000000600790351, createdTime=Thu Jan 21 20:54:19 CST 2021, time=2021-01-21, status=1, ipAttribution=)]
    2023-03-24 ms8000001004052089 来自河北省

    很需要,感谢!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2121607, encodeId=4b91212160e04, content=很需要,感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cba5468764, createdName=ms8000001004052089, createdTime=Fri Mar 24 16:23:35 CST 2023, time=2023-03-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1014498, encodeId=7eba10144984d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cac5462324, createdName=ms6000000828783892, createdTime=Sat Sep 04 10:12:43 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918788, encodeId=a9c7918e8857, content=很好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/fa25a8dd4d134574b62e806c7e35dea4/bc6f7d5f2e0d4474a8483e2a7a323f89.jpg, createdBy=21d25454526, createdName=ms1000000600790351, createdTime=Thu Jan 21 20:54:19 CST 2021, time=2021-01-21, status=1, ipAttribution=)]
    2021-09-04 ms6000000828783892

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2121607, encodeId=4b91212160e04, content=很需要,感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cba5468764, createdName=ms8000001004052089, createdTime=Fri Mar 24 16:23:35 CST 2023, time=2023-03-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1014498, encodeId=7eba10144984d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cac5462324, createdName=ms6000000828783892, createdTime=Sat Sep 04 10:12:43 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918788, encodeId=a9c7918e8857, content=很好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/fa25a8dd4d134574b62e806c7e35dea4/bc6f7d5f2e0d4474a8483e2a7a323f89.jpg, createdBy=21d25454526, createdName=ms1000000600790351, createdTime=Thu Jan 21 20:54:19 CST 2021, time=2021-01-21, status=1, ipAttribution=)]
    2021-01-21 ms1000000600790351

    很好!

    0